Paul TheisenPatient Acquisition
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Amy GilesIncreasing Engagement
Liz KaneImpactful Strategy
Bud BilanichSuccess Coach
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
Stacey GandlerBrand Nourishment
Joey CohenMedication Adherence
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
SOUTH SAN FRANCISCO, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...
- Favorable Safety Profile at Dose Levels Below 100 mg; 10 mg and 50 ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email